ABOUT THE EXPERT
Professor of Internal Medicine, Section of Medical Oncology
Associate Cancer Center Director, Clinical Research
Chief Clinical Research Officer
Yale Cancer Center
Yale School of Medicine
New Haven, CT
Ian Krop, MD, PhD, is professor of internal medicine, Section of Medical Oncology, Yale School of Medicine. He is also associate cancer center director, Clinical Research, and chief clinical research officer, Yale Cancer Center. Additionally, he serves as the chief scientific officer for the Translational Breast Cancer Research Consortium.
Dr Krop received his undergraduate, medical, and PhD degrees from Johns Hopkins University. He subsequently completed his residency in internal medicine at The Johns Hopkins Hospital and a fellowship in hematology and medical oncology at Dana-Farber Cancer Institute.
He is a translational investigator focused on the development of novel, molecularly targeted therapies and immunotherapies for breast cancer and on elucidating the mechanisms of resistance to these treatments. The majority of his efforts are concentrated in the area of HER2+ breast cancer. Dr Krop was a leader in the development of the antibody-drug conjugates trastuzumab emtansine (T-DM1) and trastuzumab deruxtecan.